Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission

Journal of Medicinal Chemistry

Volumn 41, Issue 25, 1998, Pages 4927-4932

  Leydet, Alain ^a   Moullet, Céline ^a   Roque, Jean Pierre ^a   Witvrouw, Myriam ^b   Pannecouque, Christophe ^b   Andrei, Graciela ^b   Snoeck, Robert ^b   Neyts, Johan ^b   Schols, Dominique ^b   De Clercq, Erik ^b  

^a UNIV MONTPELLIER   (France)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL COMPOUND; ALPHA CYCLODEXTRIN; AMPHOLYTE; ANTIRETROVIRUS AGENT; BETA CYCLODEXTRIN; BUTYRONITRILE; CYCLODEXTRIN DERIVATIVE; CYSTEINE; GAMMA CYCLODEXTRIN; N,N DIMETHYLFORMAMIDE; POLYANION; PROPIONIC ACID DERIVATIVE; THIOMALIC ACID;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DERIVATIZATION; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; SIMIAN IMMUNODEFICIENCY VIRUS; VERO CELL; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS TRANSMISSION;

ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CARBOHYDRATE SEQUENCE; CARBOXYLIC ACIDS; CELL LINE; CERCOPITHECUS AETHIOPS; CYCLODEXTRINS; DNA VIRUSES; DOGS; HELA CELLS; HIV-1; HIV-2; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RNA VIRUSES; STRUCTURE-ACTIVITY RELATIONSHIP; ULTRAVIOLET RAYS; VERO CELLS; VIRUS REPLICATION;

EID: 7844226324     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970661f     Document Type: Article

References (34)

1. (a) Baba, M.; Nakajima, M.; Schols, D.; Pauwels, R.; Balzarini, J.; De Clercq, E. Pentosanpolysulfate, a Sulfated Oligosaccharide, is a Potent and Selective Anti-HIV agent in vitro. Antiviral Res. 1988, 9, 335-343.
2. (b) Haseltine, W. B. Replication and Pathogenesis of AIDS Virus. J. Acquir. Immune Defic. Syndr. 1988, 1, 217-240.
3. (c) De Clercq, E. Chemotherapeutic Approaches to the Treatment of the Acquired Immune Deficiency Syndrome (AIDS). J. Med. Chem. 1986, 29, 1561-1569.
4. (a) Baba, M.; Pauwels, R.; Balzarini, J.; Desmyter, J.; De Clercq, E. Mechanism of Inhibitory Effect of Dextran Sulphate and Heparin on Replication of Human Immunodeficiency Virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6132-6136.
5. (b) Mitsuya, H.; Looney, D. J.; Kuno, S.; Ueno, R.; Wong-Staal, F.; Broder, S. Dextran Sulphate Suppression of Virus in the HIV Family: Inhibition of Virion Binding to CD4+ cells. Science 1988, 240, 646-649.
6. Neyts, J.; De Clercq, E. Effect of polyanionic compounds on intracutaneous and intravaginal herpes virus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10, 8-12.
7. Ueno, R.; Kuno, S. Dextran Sulfate, a Potent Anti-HIV Agent in vitro having Synergism with Zidovudine. Lancet 1987, 1, 1379.
8. (a) Ito, M.; Baba, M.; Pauwels, R.; De Clercq, E.; Shigeta, S. Inhibitory Effect of Dextran Sulfate and Heparin on the Replication of Human Immunodeficiency Virus (HIV) in vitro. Antiviral Res. 1987, 7, 361-367.
9. (b) Cushman, M.; Wang, P.; Chang, S. H.; Wild, C.; De Clercq, E.; Schols, D.; Goldman, M. E.; Bowen, J. A. Preparation and Anti-HIV Activities of Aurintri-carboxylic Acid Fractions and Analogues: Direct Correlation of Antiviral Potency with Molecular Weight. J. Med. Chem. 1991, 34, 329-337.
10. Yoshida, O.; Nakashima, H.; Toshida, T.; Kanedo, Y.; Matsuzaki, K.; Uryu, T.; Yamamoto, N. Sulfatation of the Immunomodulating Polysaccharide Lentinan: a Novel Strategy for Antivirals to Human Immunodeficiency Virus (HIV). Biochem. Pharmacol. 1988, 37, 2887-2889.
11. (a) Balzarini, J.; Mitsuya, H.; De Clercq, E.; Broder, S. Aurintrocarboxylic Acid and Evans Blue Represent Two Different Classes of Anionic Compounds wich Selectively Inhibit the Cytopathogenicity of Human T-cell Lymphotropic Virus Type III/ Lymphadenopathy-associated Virus. Biochem. Biophys. Res. Commun. 1986, 136, 64-71.
12. (b) Cushman, M.; Wang, P.; Chang, S. H.; Wild, C.; De Clercq, E.; Schols, D.; Goldman, M. E.; Bowen, J. A. Preparation and Anti-HIV Activities of Aurintricarboxylic Acid Fractions and Analogues: Direct Correlation of Antiviral Potency with Molecular Weight. J. Med. Chem. 1991, 34, 329-337.
13. Baba, M.; Schols, D.; De Clercq, E.; Pauwels, R.; Nagy, M.; Györgyi-Edelényi, J.; Löw, M.; Görög, S. Novel Sulfated Polymers as Highly Potent and Selective Inhibitors of Human Immunodeficiency Virus Replication and Giant Cell Formation. Antimicrob. Agents Chemother. 1990, 34, 134-138.
14. (a) Leydet, A.; Barthélémy, P.; Boyer, B.; Lamaty, G.; Roque, J. P.; Bousseau, A.; Evers, M.; Henin, Y.; Snoeck, R.; Andrei, G.; Ikeda, S.; Reymen, D.; De Clercq, E. Polyanion Inhibitors of Human Immunodeficiency Virus and Others Viruses. Part I.-Polymerized Anionic Surfactants. J. Med. Chem. 1995, 38, 2433.
15. (b) Leydet, A.; El Hachemi, H.; Boyer, B.; Lamaty, G.; Roque, J. P.; Schols, D.; Snoeck, R.; Andrei, G.; Ikeda, S.; Neyts, J.; Reymen, D.; Este, J.; Witvrouw, M.; De Clercq, E. Polyanion inhibitors of human immunodeficiency virus and others viruses. Part II. Polymerized anionic surfactants derived from amino acids and dipeptides. J. Med. Chem. 1996, 39, 1626.
16. (c) Leydet, A.; Jeantet-Seconds, C.; Barthélémy, P.; Boyer, B.; Roque, J. P. Polyanion inhibitors of human immunodeficiency virus. Part III.-Polymerized anionic surfactants derived from glucose. Recl. Trav. Chim. Pays-Bas 1996, 115, 421-426.
17. (d) Leydet, A.; Barthélémy, P.; Boyer, B.; Lamaty, G.; Roque, J. P.; Witvrouw, M.; De Clercq, E. Polyanion inhibitors of human immunodeficiency virus. Part IV. Polymerized anionic surfactants: influence of the density and distribution of anionic groups on the antiviral activity. Bioorg. Med. Chem. Lett. 1996, 6, 397.
18. (a) Anand, R.; Nayyar, S.; Pitha, J.; Merril, C. R. Sulphated Sugar Alpha-Cyclodextrin Sulphate, a Uniquely Potent Anti-HIV Agent, also Exhibits Marked Synergism with AZT, and Lymphoproliferative Activity. Antiviral Chem. Chemother. 1990, 7, 41-46.
19. (b) Schols, D.; De Clercq, E.; Witvrouw, M.; Nakashima, H.; Snoeck, R.; Pauwels, R.; Van Schepdael, A.; Claes, P. Sulphated Cyclodextrins Are Potent Anti-HIV Agents Acting Synergistically with 2′,3′-Dideoxynucleoside Analogues. Antiviral Chem. Chemother. 1991, 2, 45-53.
20. (c) Moriya, T.; Kurita, H.; Matsumoto, K.; Otake, T.; Mori, H.; Morimoto, M.; Ueba, N.; Kunita, N. Potent Inhibitory Effect of a Series of Modified Cyclodextrin Sulfates (mCDS) on the Replication of HIV-1 in vitro. J. Med. Chem. 1991, 34, 2301-2304.
21. (d) Moriya, T.; Saito, K.; Kurita, H.; Matsumoto, K.; Otake, T.; Mori, H.; Morimoto, M.; Ueba, N.; Kunita, N. A New Candidate for an Anti-HIV-1 Agent: Modified Cyclodextrin sulfate (mCDS71). J. Med. Chem. 1993, 36, 1674-1677.
22. (e) Otake, T.; Schols, D.; Witvrouw, M.; Naesens, L.; Nakashima, H.; Moriya, T.; Kurita, H.; Matsumoto, K.; Ueba, N.; De Clercq, E. Modified Cyclodextrin Sulphates (mCDS11) Have Potent Inhibitory Activity against HIV and Oral Bioavailability. Antiviral Chem. Chemother. 1994, 5, 155-161.
23. Leydet, A.; Jeantet-Segonds, C.; Bouchitté, C.; Moullet, C.; Boyer, B.; Roque, J. P.; Witvrouw, M.; Este, J.; Snoeck, R.; Andrei, G.; De Clercq, E. Polyanion Inhibitors of Human Immunodeficiency Virus and Others Viruses. Part VI - Micelle Like Anti-HIV Polyanionic Compounds Based on a Carbohydrate Core. J. Med. Chem. 1997, 40, 350-356.
24. Brimacombes, J. S.; Jones, B. D.; Stacey, M.; Willard, J. Alkylation of Carbohydrates using Sodium Hydride. J. Carbohydr. Res. 1966, 2, 167-169.
25. Pallaud, J. F.; Pallaud, R. On the Radical Addition of Thiols on Allylic Compounds with Diterbutylperoxide Initiator. C. R. Acad. Sci. (Fr.) 1970, 270, 2150-2153.
26. For a review on the subject, see: Griesbaum, K. Problems and Possibilities of the Free Radical Addition of Thiols to Unsaturated Compounds. Angew. Chem., Int. Ed. Engl. 1970, 9, 273-287.
27. Nefkens, G. H. L.; Zwanenburg, B. Boroxazolidones as Simultaneous Protection of the Amino and Carboxyl Group in α-Amino Acids. Tetrahedron 1983, 39, 2995-2998.
28. Yang, L.; Weber, A. E.; Greenlee, W. J.; Patchett, A. A. Macrocyclic Renin Inhibitors: Synthesis of a Subnanomolar, Orally Active Cysteine Derived Inhibitor. Tetrahedron Lett. 1993, 34, 44, 7035-7038.
29. (a) Ikeda, S.; Neyts, J.; Verma, S.; Wickramasinghe, A.; Mohan, P.; De Clercq, E. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. Antimicrob. Agents Chemother. 1994, 38, 256-259.
30. (b) Schols, D.; De Clercq, E.; Balzarini, J.; Baba, M.; Witvrouw, M.; Hosoya, M.; Andrei, G.; Snoeck, R.; Neyts, J.; Pauwels, R.; Nagy, M.; Györgi-Edelényi, J.; Machovich, R.; Horwath, I.; Löw, M.; Görög, S. Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, and arena- and retroviruses. Antiviral Chem. Chemother. 1990, 1, 233-240.
31. (c) Vandamme, A.-M.; Witvrouw, M.; Pannecouque, C.; Balzarini, J.; Schmit, J.-C.; Desmyter, J.; De Clercq, E. Evaluating clinical isolates for their phenotypic and genotypic resistance against anti-HIV drugs. In Methods in Molecular Biology: Antiviral Testing; Kinchington, D., Shinazi, R. F., Eds.; The Humana Press: Totowa, NJ; in press, 42p.
32. (d) Witvrouw, M.; Schols, D.; Andrei, G.; Snoeck, R.; Ikeda, S.; Pauwels, R.; Van Schepdael, A.; Arnout, J.; Claes, P.; Desmyter, J.; De Clercq, E. New polyacetal polysulphate active against human immunodeficiency virus and other enveloped viruses. Antiviral Chem. Chemother. 1992, 3, 351-360.
33. (e) Witvrouw, M.; Balzarini, J.; Pannecouque, C.; Jhaumeer-Laulloo, S.; Esté, J. A.; Schols, D.; Cherepanov, P.; Schmit, J.-C.; Debyser, Z.; Vandamme, A.-M.; Desmyter, J.; Ramadas, S. R.; De Clercq, E. SRR-SB3, a disufide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus. Antimicrob. Agents Chemother. 1997, 41, 262-268.
34. (f) Yamamoto, N.; Schols, D.; De Clercq, E.; Debyser, Z.; Pauwels, R.; Balzarini, J.; Nakashima, H.; Baba, M.; Hosoya, M.; Snoeck, R.; Neyts, J.; Andrei, G.; Murrer, B.; Theobald, B.; Bossard, G.; Henson, G.; Abrams, M.; Picker, D. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Mol. Pharmacol. 1992, 42, 1109-1117.